Search
for
Sort by
Research 241–270 of 1000+
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Granzyme B in Autoimmune Skin Disease
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- Extracellular Vesicles: Emerging Therapeutics in Cutaneous Lesions
- Cardiovascular Disease-Associated Skin Conditions
- Concise Review: Tissue-Engineered Skin and Nerve Regeneration in Burn Treatment
- Corticotropin releasing hormone and the skin
- The role of the skin microbiome in wound healing
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human Skin
- Cellular heterogeneity and microenvironmental control of skin cancer
- Psychoactive drugs and skin
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Protective Role of Melatonin and Its Metabolites in Skin Aging
- The influence of interferon on healthy and diseased skin
- Hair Follicle–Derived Blood Vessels Vascularize Tumors in Skin and Are Inhibited by Doxorubicin
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Cosmetic and Dermatological Properties of Olive Oil Byproduct-Supplemented Skin and Hair Care Products
- Medicalized Aesthetic Uses of Exosomes and Cell Culture-Conditioned Media: Opening an Advanced Care Era for Biologically Inspired Cutaneous Prejuvenation and Rejuvenation
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- An Insight on Ellagic Acid Formulations for the Management of Skin Diseases
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Spatiotemporal Labeling of Melanocytes in Mice
- Nutritional Dermatoses in the Hospitalized Patient
- A Rare Case of Cutis Verticis Gyrata with Underlying Cerebriform Intradermal Nevus
- Inducible cre-mediated N-ras activation and PTEN inactivation in transgenic mouse melanocytes requires keratinocyte hyperplasia to elicit a melanocyte pathology
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Skin Manifestations of Targeted Antineoplastic Therapy